L’Occitane Expands Fragrance Business with Acquisition of Dr. Vranjes Firenze
L’Occitane Group expands its product portfolio with the acquisition of Italian luxury home fragrance brand Dr. Vranjes Firenze.
Founded in 1983 by Paolo Vranjes, the Tuscan brand Dr. Vranjes Firenze sells its products in more than 75 countries through a strong network of 28 single-brand stores and 650 points of sale. Dr. Vranjes has been at the forefront of luxury home fragrance for over 40 years, focusing on in-house production and research and development. The brand delivers a "Made in Florence" experience through its range of home diffusers, candles and personal fragrances, which form an integral part of its product portfolio.
With this business, for an undisclosed amount, L'Occitane Group intends to continue building a "strong geographically balanced portfolio of premium beauty and fragrance brands".
L'Occitane Group Chairman Reinold Geiger said, with the addition of Dr. Vranjes Firenze, the company is pleased to continue to expand its global brand portfolio, which complements the company's existing range of premium beauty and fragrance brands. Each brand has a strong personality and a genuine desire to make a difference.
Paolo Vranjes, founder and chairman of Dr. Vranjes Firenze, said his company’s brand has undergone meaningful development while paying tribute to the rich legacy of Dr. Vranjes Firenze. and is extremely proud to hand over the legacy of Dr. Vranjes Firenze to the L’Occitane Group, renowned for its tradition of excellence and broad global reach.
The transaction is expected to close by the end of the first quarter of 2024.
China agrochemical industry weekly(0105)
2026-09-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
L’Occitane and Carbios launch PET bottle made with enzymatic recycling in Europe
-
L’Occitane's Breakthrough: A Sustainable Revolution in Hand Cream Packaging
-
L’OCCITANE REPORTS 8 PERCENT GROWTH FOR Q3 SALES; FEELS HIT OF CHINA’S COVID-19 EXIT STRATEGY
-
Ineos Exits Sinopec Tianjin Joint Venture, Pays $120 Million "Breakup Fee"
-
Evonik Reports Strong Q2 Results as Supply Chain Disruptions Boost Chemical Margins
-
Lenzing Group, a European fiber giant with over a century of history, is being forced to close two plants and cut 2,000 jobs globally
-
Luyin Investment subsidiary Heze Salt introduces Wanhua Chemical as strategic investor with RMB 333 million capital increase
-
Sinopec and CNAF to Implement Restructuring
-
Dow Europe Raises Polyurethane Prices in EMEA and India
-
As Middle East Supply Faces Disruptions, SABIC's 1.8 Million Mt/Year Methanol New Project Secures Saudi Feedstock Quota
Recommend Reading
-
Dow Chemical Weighs Exit from $20 Billion Chemical Joint Venture with Saudi Aramco
-
Merck Establishes New Semiconductor Hub in Taiwan
-
Samsung Biologics Launches Formal Bid for PolyPeptide, Reshaping the Global Peptide API CDMO Map
-
Eurofragance Opens New Creative Center in Jakarta to Expand Its Asian Footprint
-
Another Strategic Move! DuPont Launches a New Specialty Lubricants Project in Zhangjiagang
-
This Week's Aniline Market Shows High Prices (8.31-9.4) in China
-
This week, sodium metabisulfite prices rose in China (8.3-8.7)
-
Business Society’s Urea Market Outlook on September 4, 2026: Volatile
-
Business Society Epoxy Resins Daily Report: Overall Stability on August 7, 2026
-
Cost Support: Activated Carbon Prices Rise
- Hot Searches
- denatured alcohol supplier
- price of ethylene
- pet prices
- cetilistat buy
- research chemicals supplier
- aeo 7 surfactant
- mono propylene glycol for sale
- methanol price per gallon
- price of methylamine
- brand name testosterone cypionate
- cafestol palmitate cat. no. hy-138164 purity
- tci 4-chlorobenzaldehyde 25 g price